Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

This publication has 29 references indexed in Scilit:

• Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
  Published by Elsevier ,1990
• Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin.
  Journal of Clinical Investigation, 1987
• A review of possible roles of the platelet 12-lipoxygenase.
  Circulation, 1985
• Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: Coupling of receptors with high-affinity GTPase and adenylate cyclase
  Thrombosis Research, 1985
• Elevation of cytoplasmic free calcium concentration by stable thromboxane A2 analogue in human platelets
  Biochemical and Biophysical Research Communications, 1983
• Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production
  Biochemical Pharmacology, 1982
• COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H₂‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H₂ AND THROMBOXANE A₂ ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONS
  British Journal of Pharmacology, 1981
• Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A ₂
  Science, 1976
• Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
  Nature New Biology, 1971
• EFFECTS OF SALICYLATES ON HUMAN PLATELETS
  The Lancet, 1968